Found: 70
Select item for more details and to access through your institution.
A roadmap towards improving outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01115-6
- By:
- Publication type:
- Article
Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French severe congenital neutropenia registry.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Evolving Role of Stem Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 89
- By:
- Publication type:
- Article
Maintenance therapy in multiple myeloma.
- Published in:
- Hematology Reviews, 2009, v. 1, n. 2, p. 65, doi. 10.4081/hr.2009.e12
- By:
- Publication type:
- Article
Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment.
- Published in:
- Journal of Bone & Mineral Research, 1999, v. 14, n. 12, p. 2048, doi. 10.1359/jbmr.1999.14.12.2048
- By:
- Publication type:
- Article
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 4, p. 663, doi. 10.1007/s00277-014-2259-x
- By:
- Publication type:
- Article
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 8, p. 1289, doi. 10.1007/s00277-012-1429-y
- By:
- Publication type:
- Article
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Multiple Myeloma in the Elderly: When to Treat, When to Go to Transplant.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 11, p. 992
- By:
- Publication type:
- Article
COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ovarian transposition by laparoscopy before radiotherapy in the treatment of hodgkin's disease.
- Published in:
- Cancer (0008543X), 1998, v. 83, n. 7, p. 1420, doi. 10.1002/(SICI)1097-0142(19981001)83:7<1420::AID-CNCR20>3.0.CO;2-5
- By:
- Publication type:
- Article
High dose radiochemotherapy followed by autologous stem cell transplantation in four patients with multiple lymphomatous polyposis.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma--a "France autogreffe" study.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Pegylated Liposomal Doxorubicin plus Bortezomib in Relapsed or Refractory Multiple Myeloma: Efficacy and Safety in Patients with Renal Function Impairment.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 6, p. 352
- By:
- Publication type:
- Article
Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 38, doi. 10.3816/CLML.2010.n.120
- By:
- Publication type:
- Article
Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 44, doi. 10.3816/CLML.2011.n.005
- By:
- Publication type:
- Article
Ten Years of Improvement in the Management of Multiple Myeloma: 2000-2010.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 424, doi. 10.3816/CLML.2010.n.076
- By:
- Publication type:
- Article
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 3, p. 249, doi. 10.1111/j.1600-0609.2011.01729.x
- By:
- Publication type:
- Article
Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 4, p. 297, doi. 10.1111/j.1600-0609.2007.00915.x
- By:
- Publication type:
- Article
Combined Pegylated Liposomal Doxorubicin and Bortezomib Is Highly Effective in Patients With Recurrent or Refractory Multiple Myeloma Who Received Prior Thalidomide/Lenalidomide Therapy.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 7, p. 1529, doi. 10.1002/cncr.23326
- By:
- Publication type:
- Article
A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. S3, p. 887, doi. 10.1002/cncr.11138
- By:
- Publication type:
- Article
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Prognostic impact of <sup>18</sup>F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 9, p. 1633, doi. 10.1007/s00259-010-1469-2
- By:
- Publication type:
- Article
Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 1, p. 55, doi. 10.2165/00019053-200927010-00006
- By:
- Publication type:
- Article
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 11, p. 759, doi. 10.1007/s00277-006-0151-z
- By:
- Publication type:
- Article
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 3, p. 193, doi. 10.1007/s00280-004-0794-1
- By:
- Publication type:
- Article
Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00645-1
- By:
- Publication type:
- Article
Comprehensive Review of AL amyloidosis: some practical recommendations.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00486-4
- By:
- Publication type:
- Article
Amplification of the 11q23 region in acute myeloid leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 26, n. 2, p. 166, doi. 10.1002/(SICI)1098-2264(199910)26:2<166::AID-GCC9>3.0.CO;2-P
- By:
- Publication type:
- Article
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 24, n. 1, p. 9, doi. 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K
- By:
- Publication type:
- Article
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 23, n. 2, p. 175, doi. 10.1002/(SICI)1098-2264(199810)23:2<175::AID-GCC11>3.0.CO;2-N
- By:
- Publication type:
- Article
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 12, p. 1052, doi. 10.1002/ajh.23311
- By:
- Publication type:
- Article
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Prise en charge du myélome multiple en première rechute après autogreffe de cellules souches périphériques.
- Published in:
- Hematologie, 2016, v. 22, n. 6, p. 395, doi. 10.1684/hma.2016.1188
- By:
- Publication type:
- Article
Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progression.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 16, p. 3758, doi. 10.1002/cncr.25937
- By:
- Publication type:
- Article
Monoclonal antibodies in the treatment of multiple myeloma.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 6, p. 745, doi. 10.1111/j.1365-2141.2011.08790.x
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a consensus statement.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
- By:
- Publication type:
- Article
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 4, p. 531, doi. 10.1111/j.1365-2141.2009.07875.x
- By:
- Publication type:
- Article
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
- By:
- Publication type:
- Article
Persistence of CD33 expression at relapse in CD33<sup>+</sup> acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 222, doi. 10.1111/j.1365-2141.2008.07321.x
- By:
- Publication type:
- Article
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 1, p. 46, doi. 10.1111/j.1365-2141.2008.07303.x
- By:
- Publication type:
- Article
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 5, p. 429, doi. 10.1111/j.1365-2141.2007.06585.x
- By:
- Publication type:
- Article
Lack of CD27 in myeloma delineates different presentation and outcome.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 2, p. 168, doi. 10.1111/j.1365-2141.2005.05849.x
- By:
- Publication type:
- Article
Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 2, p. 434, doi. 10.1046/j.1365-2141.2002.03640.x
- By:
- Publication type:
- Article